LV Management Group, LLC, President and CEO at Protagonist Therapeutics, Inc (PTGX), sold 125,000 shares at $145.87 ($18.2M) on 2026-09-08, disclosed to the SEC on 2026-09-10.
Scheduled sale ($18.2M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $145.87 | 54,174 | $7.9M | 43.3% |
| 2 | $146.18 | 63,548 | $9.3M | 50.9% |
| 3 | $144.10 | 7,278 | $1.0M | 5.7% |
| Total | $145.92 avg | 125,000 | $18.2M | 100% |